- Home
- BCYC vs BLDP Comparison
BCYC vs BLDP Comparison
Compare BCYC & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- BLDP
- Stock Information
- Founded
- BCYC 2009
- BLDP 1979
- Country
- BCYC United Kingdom
- BLDP Canada
- Employees
- BCYC N/A
- BLDP N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- BLDP Industrial Machinery/Components
- Sector
- BCYC Health Care
- BLDP Energy
- Exchange
- BCYC Nasdaq
- BLDP Nasdaq
- Market Cap
- BCYC 492.1M
- BLDP 479.7M
- IPO Year
- BCYC 2019
- BLDP 1995
- Fundamental
- Price
- BCYC $6.90
- BLDP $2.02
- Analyst Decision
- BCYC Buy
- BLDP Sell
- Analyst Count
- BCYC 11
- BLDP 9
- Target Price
- BCYC $22.91
- BLDP $1.50
- AVG Volume (30 Days)
- BCYC 233.2K
- BLDP 3.8M
- Earning Date
- BCYC 10-30-2025
- BLDP 11-04-2025
- Dividend Yield
- BCYC N/A
- BLDP N/A
- EPS Growth
- BCYC N/A
- BLDP N/A
- EPS
- BCYC N/A
- BLDP N/A
- Revenue
- BCYC $19,281,000.00
- BLDP $72,507,000.00
- Revenue This Year
- BCYC N/A
- BLDP $28.04
- Revenue Next Year
- BCYC $0.27
- BLDP $20.42
- P/E Ratio
- BCYC N/A
- BLDP N/A
- Revenue Growth
- BCYC N/A
- BLDP N/A
- 52 Week Low
- BCYC $6.10
- BLDP $1.00
- 52 Week High
- BCYC $28.67
- BLDP $2.28
- Technical
- Relative Strength Index (RSI)
- BCYC 39.17
- BLDP 55.47
- Support Level
- BCYC $6.84
- BLDP $1.85
- Resistance Level
- BCYC $7.32
- BLDP $2.12
- Average True Range (ATR)
- BCYC 0.36
- BLDP 0.10
- MACD
- BCYC 0.01
- BLDP 0.00
- Stochastic Oscillator
- BCYC 14.56
- BLDP 63.79
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About BLDP Ballard Power Systems Inc.
Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from Poland followed by United States, United Kingdom, and other countries.